Recruiting

Digital Anesthesia

Sponsor:

Kevin Zuo

Code:

NCT06476977

Conditions

Trigger Finger Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dorsal webspace combined corticosteroid and anesthetic injection

Palmar combined corticosteroid and anesthetic injection

Study Details

Brief summary:

Trigger finger is a common disease of the hand involving swelling and inflammation of the tendon which flexes a finger, causing catching, locking, and/or pain. Trigger finger is typically treated by hand surgeons with a steroid injection through the front/palm side of the hand into the area near the tendon (i.e., at the base of the affected finger). This steroid injection is often combined with a local anesthetic (numbing agent) to help reduce short-term pain from the injection. However, the front/palm side of the hand is known to be very sensitive, and the steroid injection can be quite painful as the needle pierces the front/palm skin.

To reduce the pain of steroid injections for trigger finger, a different approach involves performing the injection from the back/dorsal side of the hand, which is thought to be less sensitive (and therefore less painful) than the front/palm side of the hand. This technique is sometimes used and has been previously studied, but it is not clear if it can offer less injection-related pain than standard treatment.

Accordingly, this study will be comparing short-term injection-associated pain between front/palm side and back/dorsal side steroid injections for trigger finger. The study will also seek to understand what area of the hand is numbed by the anesthetic when doing a front/palm side injection versus a back/dorsal side injection of the hand. Overall, the investigators hypothesize that back/dorsal side injections will be less painful than front/palm side injections for trigger fingers and that the area of numbing from the anesthetic will be equivalent between both types of injections.

Conditions

Trigger Finger Disorder

Study ID

NCT06476977

Start date

Jul 3, 2024

Status verified date

Aug, 2024

Completion date

Jul, 2026

Anticipated

Primary completion date

Feb, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Be 18 years of age or older
  • Have a diagnosis of trigger finger (can be any of the 5 digits)
  • Opting to receive a CSI for their triggering finger

Exclusion Criteria:

  • Decline to obtain a CSI for trigger finger management
  • Receiving multiple CSI for trigger finger management at the appointment
  • Past CSI and/or surgery to the digit involved
  • Unable to communicate in English

Study Design

Enrollment

60 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Dorsal Webspace Approach

A dorsal approach involves passing the needle with a 1:1 triamcinolone and lidocaine mixture in the dorsal webspace skin aiming just palmar to the proximal phalanx bone such that the needle is directed into the flexor tendon sheath at the A1 annular pulley.

active comparator: Palmar Approach

Standard approach for injecting the 1:1 triamcinolone and lidocaine mixture involves the needle passing through the cutaneous and subcutaneous layers of the palmar skin surface and into the flexor tendon sheath at the A1 annular pulley.

Interventions

Dorsal webspace combined corticosteroid and anesthetic injection

The dorsal webspace injection consists of a 1cc mixture of 0.5cc triamcinolone (Kenalog) 10mg/mL and 0.5cc 1% lidocaine for analgesic purposes.

Palmar combined corticosteroid and anesthetic injection

The palmar injection consists of a 1cc mixture of 0.5cc triamcinolone (Kenalog) 10mg/mL and 0.5cc 1% lidocaine for analgesic purposes.

Primary outcome measure

  • Visual Analogue Scale (VAS) - Pain [ Time Frame: measured at 0 hours, 4 hours, and 24 hours post-injection ]
  • Numerical Rating Scale (NRS) - Pain [ Time Frame: measured at 0 hours, 4 hours, and 24 hours post-injection ]
  • Short-Form McGill Pain Questionnaire (SFMPQ) - Present Pain Intensity (PPI) [ Time Frame: measured at 0 hours, 4 hours, and 24 hours post-injection ]

Central Contacts and Locations

Central contacts

Locations

University Health Network - Toronto Western Hospital

Recruiting

Toronto, Ontario, Canada, M5T 2S8

Contacts

Principal Investigator:

Kevin Zuo, MD, MASc

More Information

Sponsor

Kevin Zuo

Last update posted

Aug 19, 2024

Last verified

Aug, 2024

Keywords

  • trigger finger
  • stenosing tenosynovitis
  • corticosteroid injection
  • palmar
  • dorsal
  • pain

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Kevin Zuo on 2024-08-19.